Guillo, Lucas http://orcid.org/0000-0001-9024-8541
Amiot, Aurélien
Serrero, Mélanie
Altwegg, Romain
Roblin, Xavier
Atanasiu, Calina
Buisson, Anthony
Le Berre, Catherine
Reenaers, Catherine
Gornet, Jean-Marc
Laharie, David
Abitbol, Vered
Biron, Amélie
Caron, Bénédicte
Nancey, Stéphane
Chupin, Antoine
Blain, Antoine
Vuitton, Lucine
Caillo, Ludovic
Kirchgesner, Julien
Nachury, Maria
Peyrin-Biroulet, Laurent
Pariente, Benjamin
Beaugerie, Laurent
Seksik, Phillipe
Bourrier, Anne
Bourrreille, Arnaud
Desjeux, Ariadne
Savoye, Guillaume
Auzou, Stéphanie
Cadiot, Guillaume
Benezech, Alban
Mathieu, Nicolas
Malamut, Georgia
Amouriaux, Karine
Brixi, Hédia
Simon, Marion
Benitah, Daniel
Ah-Soune, Philippe
Fumery, Mathurin
Boschetti, Gilles
Gay, Claire
Vidon, Mathias
Fotsing, Ginette
Coffin, Benoit
Gilletta, Cyrielle
Reimund, Jean Marie
Bonnet-Dodel, Marie
,
Funding for this research was provided by:
pfizer
Article History
Received: 23 July 2021
Accepted: 18 November 2021
First Online: 4 March 2022
Declarations
:
: L Guillo declares consulting fees for Abbvie. A Amiot declares counseling, boards, lecture, transports or fees from Abbvie, Hospira, Takeda, Gilead, Biocodex, Janssen, Ferring and MSD. M Serrero declares lecture and consulting fees for Abbvie, Celltrion, Ferring, Janssen, MSD, Takeda and Tillotts. R Altwegg declares counseling, boards, transports or fees from Abbvie, Amgen, Biogen, Ferring, Janssen, MSD, Pfizer, Takeda, Tillotts. A Buisson declares lecture and consulting fees for Abbvie, Amgen, Arena, Biogen, Janssen, MSD, Mayoly-Spindler, Norgine, Pfizer, Roche, Takeda and Tillots. C Le Berre has served as a consultant for Janssen and Gilead; reports receiving payment for lectures from AbbVie, Ferring Janssen, MSD, Pfizer and Takeda. C Reenaers has served as a speaker and advisory board member for Abbvie, Janssen, Pfizer, Takeda, Celltrion. JM Gornet has received personal fees from Amgen, Janssen Cilag, Sanofi,Takeda, Roche and Tillots Pharma. D Laharie declares counseling, boards, transports or fees from Abbvie, Biogaran, Biogen, BMS, Ferring, HAC-pharma, Janssen, Gilead, MSD, Novartis, Pfizer, Prometheus, Roche, Takeda, Theradiag, Tillots. V Abitbol declares counseling, boards, transports or fees from Janssen, Takeda, sandoz, Mylan, Amgen, Fresenius, Tillotts, Celltrion, Gilead, Pfizer. B Caron has received lecture and/or consulting fees from Abbvie, Amgen, Celltrion, Janssen, Takeda. S Nancey declares lecture and consulting fees for Abbvie, Celltrion, Amgen, Biogen, Janssen, Hospira/Pfizer, MSD, HAC, Fresenius, Takeda, Bristol Myers Squibb and Tillotts. L Vuitton has received lecture fees from Abbvie, MSD, Takeda, Ferring, Janssen and Pfizer, and research grants from MSD, Takeda and Pfizer. L Caillo declares lecture and consulting fees for Abbvie, Pfizer, Ferring, Janssen, Amgen, Biogen, Takeda and Tillotts. J Kirchgesner declares lecture and consulting fees from Roche, Pfizer, and Gilead. M Nachury declares lecture and consulting fees for Abbvie, Adacyte, Amgen, Arena, Biogen, CTMA, Ferring, Janssen, Mayoli-Spindler, MSD, Pfizer, Takeda. L Peyrin-Biroulet has served as a speaker, consultant and advisory board member for Merck, Abbvie, Janssen, Genentech, Mitsubishi, Ferring, Norgine, Tillotts, Vifor, Hospira/Pfizer, Celltrion, Takeda, Biogaran, Boerhinger-Ingelheim, Lilly, HAC- Pharma, Index Pharmaceuticals, Amgen, Sandoz, For- ward Pharma GmbH, Celgene, Biogen, Lycera, Samsung Bioepis, Theravance. The remaining authors have no conflict of interest.